Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 13 | 2020 | 811 | 1.700 |
Why?
|
| Contrast Media | 2 | 2020 | 94 | 0.780 |
Why?
|
| Urinary Bladder | 2 | 2020 | 118 | 0.770 |
Why?
|
| Radiographic Image Enhancement | 1 | 2020 | 28 | 0.680 |
Why?
|
| Algorithms | 3 | 2020 | 422 | 0.670 |
Why?
|
| Machine Learning | 1 | 2020 | 81 | 0.650 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2009 | 285 | 0.580 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2008 | 107 | 0.520 |
Why?
|
| White Matter | 3 | 2018 | 89 | 0.400 |
Why?
|
| Pattern Recognition, Automated | 2 | 2008 | 32 | 0.370 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2008 | 128 | 0.350 |
Why?
|
| Image Enhancement | 2 | 2008 | 58 | 0.320 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2018 | 79 | 0.320 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2008 | 4 | 0.320 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 751 | 0.310 |
Why?
|
| Humans | 26 | 2022 | 27136 | 0.290 |
Why?
|
| Basilar Artery | 2 | 2004 | 7 | 0.290 |
Why?
|
| Shoulder Joint | 1 | 2007 | 10 | 0.280 |
Why?
|
| Radiation Protection | 2 | 2017 | 17 | 0.270 |
Why?
|
| Osteoarthritis | 1 | 2007 | 35 | 0.270 |
Why?
|
| Brain Neoplasms | 2 | 2022 | 298 | 0.260 |
Why?
|
| Head Movements | 1 | 2006 | 4 | 0.260 |
Why?
|
| Subtraction Technique | 1 | 2006 | 8 | 0.260 |
Why?
|
| Brain Mapping | 2 | 2016 | 199 | 0.260 |
Why?
|
| Specialization | 1 | 2005 | 19 | 0.250 |
Why?
|
| Professional Competence | 1 | 2005 | 36 | 0.250 |
Why?
|
| Medicine | 1 | 2005 | 22 | 0.250 |
Why?
|
| Sensitivity and Specificity | 4 | 2008 | 509 | 0.250 |
Why?
|
| Artifacts | 1 | 2006 | 50 | 0.250 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 62 | 0.240 |
Why?
|
| Fractures, Stress | 1 | 2005 | 4 | 0.240 |
Why?
|
| Ulna Fractures | 1 | 2005 | 3 | 0.240 |
Why?
|
| Elbow | 1 | 2005 | 15 | 0.240 |
Why?
|
| Baseball | 1 | 2005 | 10 | 0.240 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2005 | 64 | 0.240 |
Why?
|
| Intracranial Thrombosis | 1 | 2004 | 2 | 0.230 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2004 | 11 | 0.230 |
Why?
|
| Protons | 2 | 2022 | 54 | 0.230 |
Why?
|
| Mucus | 1 | 2004 | 11 | 0.230 |
Why?
|
| Spinal Fractures | 1 | 2004 | 40 | 0.230 |
Why?
|
| Thoracic Vertebrae | 1 | 2004 | 66 | 0.230 |
Why?
|
| Bone Substitutes | 1 | 2022 | 10 | 0.200 |
Why?
|
| Proton Therapy | 1 | 2022 | 28 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 466 | 0.190 |
Why?
|
| Breast Implants | 1 | 2021 | 6 | 0.190 |
Why?
|
| Middle Aged | 10 | 2022 | 6906 | 0.180 |
Why?
|
| Glioblastoma | 1 | 2022 | 101 | 0.180 |
Why?
|
| Brain | 1 | 2006 | 711 | 0.170 |
Why?
|
| Neural Pathways | 2 | 2017 | 118 | 0.170 |
Why?
|
| Preventive Medicine | 1 | 2020 | 13 | 0.170 |
Why?
|
| Carotid Arteries | 1 | 2020 | 52 | 0.170 |
Why?
|
| Diabetes Complications | 1 | 2020 | 66 | 0.160 |
Why?
|
| Models, Statistical | 2 | 2017 | 122 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2020 | 229 | 0.160 |
Why?
|
| Noise | 1 | 2018 | 15 | 0.150 |
Why?
|
| Ambulances | 1 | 2018 | 12 | 0.150 |
Why?
|
| Air Ambulances | 1 | 2018 | 19 | 0.150 |
Why?
|
| Female | 10 | 2018 | 14650 | 0.150 |
Why?
|
| Corpus Callosum | 1 | 2018 | 19 | 0.150 |
Why?
|
| Vibration | 1 | 2018 | 78 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2018 | 35 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2022 | 635 | 0.140 |
Why?
|
| Motor Cortex | 1 | 2018 | 46 | 0.140 |
Why?
|
| Neurosurgical Procedures | 2 | 2017 | 216 | 0.140 |
Why?
|
| Aged | 7 | 2022 | 5228 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2017 | 79 | 0.140 |
Why?
|
| Parietal Lobe | 1 | 2017 | 26 | 0.140 |
Why?
|
| Computer Graphics | 1 | 2016 | 10 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2016 | 51 | 0.130 |
Why?
|
| Gadolinium DTPA | 1 | 2015 | 14 | 0.130 |
Why?
|
| Phantoms, Imaging | 3 | 2022 | 98 | 0.130 |
Why?
|
| Radiography | 3 | 2005 | 201 | 0.130 |
Why?
|
| Cystitis, Interstitial | 1 | 2015 | 17 | 0.120 |
Why?
|
| Glioma | 1 | 2016 | 117 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2018 | 846 | 0.120 |
Why?
|
| Adult | 7 | 2022 | 7499 | 0.120 |
Why?
|
| Aging | 1 | 2022 | 952 | 0.120 |
Why?
|
| Male | 7 | 2018 | 13034 | 0.100 |
Why?
|
| Calibration | 2 | 2022 | 28 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 1943 | 0.100 |
Why?
|
| Genes, APC | 1 | 2010 | 14 | 0.090 |
Why?
|
| Nitrogen Oxides | 1 | 2010 | 40 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2022 | 1219 | 0.080 |
Why?
|
| Adenoma | 1 | 2010 | 59 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 155 | 0.080 |
Why?
|
| Adolescent | 2 | 2007 | 2995 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2008 | 45 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 133 | 0.070 |
Why?
|
| Cadaver | 2 | 2018 | 57 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2009 | 288 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 462 | 0.070 |
Why?
|
| Arthroscopy | 1 | 2007 | 10 | 0.070 |
Why?
|
| Shoulder Pain | 1 | 2007 | 3 | 0.070 |
Why?
|
| Radiotherapy Dosage | 3 | 2016 | 102 | 0.070 |
Why?
|
| Scattering, Radiation | 2 | 2017 | 28 | 0.070 |
Why?
|
| Connectome | 2 | 2017 | 87 | 0.070 |
Why?
|
| Observer Variation | 1 | 2005 | 43 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2006 | 49 | 0.060 |
Why?
|
| Elasticity | 1 | 2006 | 49 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2009 | 2285 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 2004 | 27 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 659 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 34 | 0.050 |
Why?
|
| Butylated Hydroxyanisole | 1 | 2022 | 2 | 0.050 |
Why?
|
| Deoxyguanosine | 1 | 2022 | 14 | 0.050 |
Why?
|
| Intracranial Aneurysm | 1 | 2003 | 55 | 0.050 |
Why?
|
| Mechanical Phenomena | 1 | 2022 | 17 | 0.050 |
Why?
|
| Silicones | 1 | 2021 | 8 | 0.050 |
Why?
|
| Water | 1 | 2022 | 131 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 111 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 156 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 353 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2007 | 2456 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 108 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 738 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 930 | 0.040 |
Why?
|
| Transportation of Patients | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 1269 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 21 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 78 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 2017 | 7 | 0.040 |
Why?
|
| Dissection | 1 | 2017 | 20 | 0.040 |
Why?
|
| Thalamus | 1 | 2017 | 26 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 595 | 0.040 |
Why?
|
| Brain Stem | 1 | 2017 | 22 | 0.040 |
Why?
|
| Facility Design and Construction | 1 | 2017 | 4 | 0.040 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 14 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2017 | 62 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2017 | 53 | 0.030 |
Why?
|
| X-Rays | 1 | 2016 | 29 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 30 | 0.030 |
Why?
|
| Stroke | 1 | 2020 | 241 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 134 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 211 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 353 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 59 | 0.030 |
Why?
|
| Young Adult | 1 | 2022 | 2631 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 191 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 2035 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 707 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 11 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2010 | 53 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 58 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 278 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 225 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 179 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 489 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2006 | 108 | 0.020 |
Why?
|
| Brachytherapy | 1 | 2006 | 50 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 1571 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1496 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1405 | 0.010 |
Why?
|
| Vertebral Artery | 1 | 2003 | 16 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 2003 | 19 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 4474 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 10085 | 0.010 |
Why?
|